BELGIUM - Capricorn launches health tech fund; expands team

Capricorn Health-tech Fund will specifically target businesses working on prevention, diagnosis or treatment of diseases, including providers of services and developers of drugs or equipment. The fund will commence investing once it has raised an initial EUR 30m.

In preparation for the fundraising, Capricorn has expanded its senior team with the appointment of Dr Frank Bulens, Dr Els Hubloux and Dr Els Vanheusden.

Bulens has extensive academic medical research experience as well as health-tech venture capital experience. In the past he has served as a senior scientific advisor at IWT and an executive investment manager at Gimv.

Hubloux has previously been involved with clinical development at pharmaceuticals business Abbott and Merck, as well financial analyst at KBC Securities and investment manager at both KBC Private Equity and Quest Management.

Prior to joining Capricorn, Vanheusden held various positions at P&G Pharmaceuticals, Guidant and J&J Medical. She is also a serial entrepreneur and has served on the board of four health technology organisations.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• Benelux